Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juswinder Singh

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Drug Discovery & Development|September 2, 2004
Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5)Juswinder Singh, Leona E Ling, J Scott Sawyer, et al.
Virology|December 25, 2012
Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organizationGillian M Schiralli Lester, Hisashi Akiyama, Erica Evans, et al.
Current Topics in Medicinal Chemistry|November 17, 2004
Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthmaJuswinder Singh, Steve Adams, Mary Beth Carter, et al.
The Journal of Investigative Dermatology|June 3, 2006
Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivoWataru Ishida, Yasuji Mori, Gabriella Lakos, et al.
Chemical Biology & Drug Design|August 3, 2006
A kinase-focused compound collection: compilation and screening strategyDongyu Sun, Claudio Chuaqui, Zhan Deng, et al.
European Journal of Biochemistry|August 16, 2003
The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysisSusan F Foley, Herman W T van Vlijmen, Raymond E Boynton, et al.
Journal of Medicinal Chemistry|June 28, 2002
Identification of potent and novel alpha4beta1 antagonists using in silico screeningJuswinder Singh, Herman Van Vlijmen, Yusheng Liao, et al.
Cancer Research|March 3, 2007
A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resectionEiji Suzuki, Samuel Kim, H-Kam Cheung, et al.
Science Signaling|October 25, 2018
A call to arms: Unifying the fight against resistanceAlexis Kaushansky, Lizbeth Hedstrom, Aaron Goldman, et al.
Journal of Computer-Aided Molecular Design|October 5, 2002
3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonistsJuswinder Singh, Herman van Vlijmen, Wen-Chemg Lee, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|September 2, 2004
Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5)Juswinder Singh, Leona E Ling, J Scott Sawyer, et al.
Virology|December 25, 2012
Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organizationGillian M Schiralli Lester, Hisashi Akiyama, Erica Evans, et al.
Current Topics in Medicinal Chemistry|November 17, 2004
Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthmaJuswinder Singh, Steve Adams, Mary Beth Carter, et al.
The Journal of Investigative Dermatology|June 3, 2006
Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivoWataru Ishida, Yasuji Mori, Gabriella Lakos, et al.
Chemical Biology & Drug Design|August 3, 2006
A kinase-focused compound collection: compilation and screening strategyDongyu Sun, Claudio Chuaqui, Zhan Deng, et al.
European Journal of Biochemistry|August 16, 2003
The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysisSusan F Foley, Herman W T van Vlijmen, Raymond E Boynton, et al.
Journal of Medicinal Chemistry|June 28, 2002
Identification of potent and novel alpha4beta1 antagonists using in silico screeningJuswinder Singh, Herman Van Vlijmen, Yusheng Liao, et al.
Cancer Research|March 3, 2007
A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resectionEiji Suzuki, Samuel Kim, H-Kam Cheung, et al.
Science Signaling|October 25, 2018
A call to arms: Unifying the fight against resistanceAlexis Kaushansky, Lizbeth Hedstrom, Aaron Goldman, et al.
Journal of Computer-Aided Molecular Design|October 5, 2002
3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonistsJuswinder Singh, Herman van Vlijmen, Wen-Chemg Lee, et al.
Pageof 3